Provider
Long Acting Insulin - Commercial
Quantity Limit
Program effective Date: May 01, 2025
Documents & Forms Results
Displaying 251 - 260 of 3159 results
Provider
Afrezza® - Medicaid
Quantity Limit
Program effective Date: May 01, 2025
Provider
Long Acting Insulin - Medicaid
Quantity Limit
Program effective Date: May 01, 2025
Provider
Interstitial Lung Disease (ILD) - Commercial
Prior Authorization, Quantity Limit
Program effective Date: May 01, 2025
Provider
Multiple Sclerosis Agents - Medicaid
Prior Authorization, Quantity Limit
Program effective Date: May 01, 2025
Provider
Multiple Sclerosis Agents - Commercial
Step Therapy, Quantity Limit
Program effective Date: May 01, 2025
Provider
Metformin ER - Commercial
Step Therapy, Quantity Limit
Program effective Date: May 01, 2025
Provider
Afrezza® (regular human insulin, inhaled) - Commercial
Prior Authorization, Quantity Limit
Program effective Date: May 01, 2025
Provider
Topical Actinic Keratosis, Basal Cell Carcinoma, Genital Wart Agents - Commercial
Prior Authorization, Quantity Limit
Program effective Date: May 01, 2025
Provider
Hereditary Angioedema (HAE) - Medicaid
Prior Authorization, Quantity Limit
Program effective Date: May 01, 2025